---
title: "Definium Therapeutics Grants Stock Options to New Employees"
description: "Definium Therapeutics Inc. has granted stock options to three new non-executive employees, totaling 88,850 common shares. The options, effective January 12 and January 26, 2025, have an exercise price"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/273745776.md"
published_at: "2026-01-26T21:01:13.000Z"
---

# Definium Therapeutics Grants Stock Options to New Employees

> Definium Therapeutics Inc. has granted stock options to three new non-executive employees, totaling 88,850 common shares. The options, effective January 12 and January 26, 2025, have an exercise price equal to the closing price on the grant dates. They will vest over four years, with 25% vesting on the first anniversary and the remaining 75% in equal monthly increments, contingent on continued employment.

Definium Therapeutics Inc. has granted options to purchase a total of 88,850 common shares to three newly hired non-executive employees. The options were granted with effective dates of January 12 and January 26, 2025, at an exercise price equal to the closing price of Definium’s common shares on the respective grant dates. The options will vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining 75% vesting in substantially equal monthly increments over the following three years, contingent on continued employment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260126110151) on January 26, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [DFTX.US - Definium Therapeutics](https://longbridge.com/en/quote/DFTX.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Definium Therapeutics Appoints Roger Adsett to Board of Directors | Definium Therapeutics Inc. has appointed Roger Adsett to its Board of Directors. Adsett has over 20 years of experience  | [Link](https://longbridge.com/en/news/274145221.md) |
| Definium Therapeutics Adds Commercial Leader As Phase 3 Milestones Approach | Definium Therapeutics has appointed Roger Adsett, a seasoned biopharmaceutical executive, to its Board of Directors as i | [Link](https://longbridge.com/en/news/274377675.md) |
| Bitwise: DeFi may lead us out of the crypto winter | Bitwise's Chief Investment Officer, Matt Hougan, highlights the potential of DeFi to emerge from the current crypto bear | [Link](https://longbridge.com/en/news/276577899.md) |
| Why Is Grayscale Buying More Cardano? Bitcoin DeFi Could Be The Answer | Grayscale has increased its Cardano (ADA) allocation in its Smart Contract Fund as Cardano ventures into Bitcoin DeFi, a | [Link](https://longbridge.com/en/news/276449884.md) |
| TEAMZ Summit 2026 – Title and Gold Sponsorships Sold Out Quickly | TEAMZ Co., Ltd. announced that all Title and Gold sponsorships for the "TEAMZ Summit 2026" have sold out, with only 1 Pl | [Link](https://longbridge.com/en/news/276701561.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.